Physician profile
Consandre Romain
NPI 1083970370
$22,857.62
in general payments reported to CMS, 2019-2025
12 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $146 · 2021: $322 · 2022: $273 · 2023: $105 · 2024: $265 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21,049.66 | 2019-2025 | Spyglass, Overstitch Endoscopic Suturing System, Axios |
| Intuitive Surgical, INC. | $966.01 | 2019-2025 | |
| Davol INC. | $410.94 | 2021-2022 | |
| Kerecis Limited | $168.51 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $75.14 | 2019-2021 | |
| Endogastric Solutions, INC | $67.61 | 2022 | |
| Pentax of America, INC. | $31.67 | 2020 | |
| Cook Medical LLC | $28.57 | 2019 | |
| Smith+Nephew, INC. | $22.57 | 2024 | Renasys Go V2 Home |
| Paratek Pharmaceuticals, INC. | $12.83 | 2020 | |
| Integra Lifesciences Corporation | $12.31 | 2019 | |
| Allergan, INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Consandre Romain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.